ad image
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Gene Editing
Sep 30, 2024

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Touchlight’s Elena Stoyanova, Ph.D., and Tom Adie, Ph.D., explain how the company’s new nonviral MegaBulb DNA (mbDNA) offers a high-purity, synthetic CRISPR ssDNA template that demonstrates remarkable efficiency and minimal toxicity.

Economic Benefits of Digital Process Development
Process Development
Sep 24, 2024

Economic Benefits of Digital Process Development

DataHow’s Fabian Feidl, Ph.D., discusses how advanced digital tools and strategies, including quality-by-design, hybrid modeling, transfer learning, and digital twins, not only enhance efficiency in process development but also substantially cut costs in manufacturing.

Building the Future of E. coli Biomanufacturing with Protein Secretion
Technology
Nov 18, 2024

Building the Future of E. coli Biomanufacturing with Protein Secretion

Vectron Biosolutions is advancing E. coli biomanufacturing with its VB Secretion Technology, enabling efficient, large-scale protein production through controlled secretion and continuous platform improvements to support diverse therapeutic and industrial applications.

Passion and Understanding Essential for Rare Disease Clinical Trials
Clinical Trials
Oct 29, 2024

Passion and Understanding Essential for Rare Disease Clinical Trials

Ergomed’s Juliet Moritz discusses some of the key ongoing challenges sponsors and CROs encounter in implementing effective clinical trials in rare disease and how Ergomed is uniquely positioned to overcome them.

Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months
PPQ
Nov 04, 2024

Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months

This white paper details a landmark project where the company successfully compressed the typical biopharmaceutical development timeline to achieve PPQ from GMP initiation in just 12 months.

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future
Cell Therapy
Sep 30, 2024

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

In this Q&A, OrganaBio’s Chief Executive Officer Justin Irizarry discusses the strategies and operational philosophies driving the company and how it plans to navigate future challenges and opportunities in the rapidly evolving cell therapy landscape.

Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO
CDMO
Oct 07, 2024

Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO

NorthX Biologics is a pioneering Swedish contract development and manufacturing organization (CDMO) that combines deep-rooted scientific heritage with cutting-edge biotechnological advancements.

A New Vision for Progressing Advanced Therapies
Advanced Therapies
Oct 25, 2024

A New Vision for Progressing Advanced Therapies

In this Q&A, ReciBioPharm’s Nathaniel Youndt discusses the company’s evolving strategy and how it is strategizing to become a leader in nucleic acid manufacturing and drive the future of advanced therapies.

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
Biopharma
Sep 27, 2024

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Fab Biopharma’s Reiner Getz, Ph.D., and Gardiner Smith, J.D. discuss how the company aims to revolutionize the treatment of complex and often life-threatening autoimmune diseases like Sjögren’s disease and lupus with its groundbreaking soluble bispecific receptor therapies

Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Biomanufacturing
Nov 11, 2024

Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing

ReciBioPharm’s flexible, digital xRNA platform revolutionizes RNA biomanufacturing by reducing time and costs, ensuring high-quality production, and enabling global access to advanced therapies.

Recommended

Frontier Scientific Solutions Unveils Plans for a Trade Zone Gateway Dedicated for Life Sciences Supply Chain
Supply Chain
Nov 15, 2024
Frontier Scientific Solutions Unveils Plans for a Trade Zone Gateway Dedicated for Life Sciences Supply Chain
Olon Releases its Annual ESG Report
Sustainability
Nov 19, 2024
Olon Releases its Annual ESG Report
PCI Pharma Services and ChiRhoClin Partner to Prevent Shortage of Critical Orphan Pancreatic Drug
Pancreatic
Nov 19, 2024
PCI Pharma Services and ChiRhoClin Partner to Prevent Shortage of Critical Orphan Pancreatic Drug

Spotlight

Olon is Ready to Host Productions in the New Facility Dedicated to Ultra-Potent Compounds
Neurocrine Biosciences Presents Breadth of Data Over Time Following Treatment With INGREZZA Capsules
Eisai Completes Submission to US FDA for LEQEMBI Application for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
PCI Pharma Services Wins Supply Chain Excellence Award for Digital Platform to Manage Clinical Trials and Commercial Lifespans
Pharma Tech Industries Names Darrin T. Schellin New CEO
Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets™
ad image
ad image

Featured Content

featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
ad image

Nice Insights

Biotech Training is a Challenge
Training
Jun 11, 2024
Biotech Training is a Challenge
Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?
Synthetic DNA
Feb 06, 2024
Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?
PROTACS: Upgrading Small Molecule Inhibitors
Protein Degradation
Jun 11, 2024
PROTACS: Upgrading Small Molecule Inhibitors
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
Drug Delivery
Aug 30, 2024
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights
Genomics
Jan 30, 2024
Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights
Cell-Free Protein Synthesis Holds Real Potential to Transform Drug Development and Manufacturing
Cell-Free
Feb 14, 2024
Cell-Free Protein Synthesis Holds Real Potential to Transform Drug Development and Manufacturing
Biotech Funding Ups and Downs
Nice Insight Reports
Apr 02, 2024
Biotech Funding Ups and Downs
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Exosomes
May 09, 2024
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Why Life Science Companies Surged amid a Global M&A Downturn
Financing
Oct 15, 2024
Why Life Science Companies Surged amid a Global M&A Downturn
Small Molecule API Discovery and Development Trends
Nice Insight API Report
Mar 21, 2024
Small Molecule API Discovery and Development Trends
Five Small Biotechs to Watch: October 2024
Biotech
Sep 23, 2024
Five Small Biotechs to Watch: October 2024
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
Outsourced Manufacturing
Mar 27, 2024
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
ad image

Top 5

ad image

Roundtable

View all roundtable
ad image

Editor's Picks

Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Biomanufacturing
Nov 11, 2024
Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Scaling Cell and Gene Therapy Processes from R&D to Production
Cell and Gene Therapy
Dec 12, 2023
Scaling Cell and Gene Therapy Processes from R&D to Production
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
dbDNA
Aug 19, 2024
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Exosomes
May 09, 2024
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Building the Future of E. coli Biomanufacturing with Protein Secretion
Technology
Nov 18, 2024
Building the Future of E. coli Biomanufacturing with Protein Secretion
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Gene Editing
Sep 30, 2024
MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing
Designing Quality into Biomanufacturing
QbD
Oct 29, 2024
Designing Quality into Biomanufacturing
Optimized Residual dsRNA Detection for mRNA Therapeutics
RNA
Sep 30, 2024
Optimized Residual dsRNA Detection for mRNA Therapeutics
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
Biopharma
Sep 27, 2024
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
A New Vision for Progressing Advanced Therapies
Advanced Therapies
Oct 25, 2024
A New Vision for Progressing Advanced Therapies
Overcoming Variability and Scaling Challenges in AAV Manufacturing
AAV
Jul 22, 2024
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future
Cell Therapy
Sep 30, 2024
Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future
ad image

Videos

View all videos
Oncology
Nov 05, 2024

Celebrating a Decade of Oncology Innovation at ONJ

In this interview, Nigel Walker speaks with Natalia Vukelic, Clinical Trials Blood Processing Researcher at the Olivia Newton-John Cancer Research Institute (ONJCRI).

Celebrating a Decade of Oncology Innovation at ONJ
Oncology
Nov 05, 2024
Celebrating a Decade of Oncology Innovation at ONJ
Kicking off Road to the Max
Cleaning
Oct 29, 2024
Kicking off Road to the Max
The Groundbreaking Potential of CRISPR Gene Editing
CRISPR
Nov 05, 2024
The Groundbreaking Potential of CRISPR Gene Editing
One of Our First Looks at the Burgeoning Australia Biotech Ecosystem
Clinical Trials
Nov 04, 2024
One of Our First Looks at the Burgeoning Australia Biotech Ecosystem
Reshaping the Approach to Therapeutic Development with i-Bodies
Antibodies
Nov 06, 2024
Reshaping the Approach to Therapeutic Development with i-Bodies
University-Industry Partnerships Tackling Genetic Disease Therapies and Diagnostic Innovation
Partnerships
Nov 06, 2024
University-Industry Partnerships Tackling Genetic Disease Therapies and Diagnostic Innovation
More Efficient and Cost-Effective Clinical Trials Down Under
Clinical Trials
Nov 06, 2024
More Efficient and Cost-Effective Clinical Trials Down Under
The Partnerships Powering Next-Gen Oncology Care
Biosensors
Nov 06, 2024
The Partnerships Powering Next-Gen Oncology Care
Why Storage and Quality Go Hand-in-Hand in Advancing Therapies
Biopreservation
Nov 04, 2024
Why Storage and Quality Go Hand-in-Hand in Advancing Therapies
Avicena Systems' Cutting-Edge Biopreparedness and Testing Platform
Diagnostics
Nov 06, 2024
Avicena Systems' Cutting-Edge Biopreparedness and Testing Platform
Modernizing Dated Approaches to Oncology Care
Chemotherapy
Nov 06, 2024
Modernizing Dated Approaches to Oncology Care
Road Tripping is Much Easier with Your Own Mechanic On Hand
Road Trip
Nov 04, 2024
Road Tripping is Much Easier with Your Own Mechanic On Hand

Latest

View all latest
ad image
ad image
A comprehensive market analysis with 110 major company profiles and detailed CDMO pricing information.

A comprehensive market analysis with 110 major company profiles and detailed CDMO pricing information.

LEARN MORE
Over 60 company profiles covering the leading mRNA and LNP contract manufacturing organizations. Unique pricing comparison for the end-to-end manufacturing process.

Over 60 company profiles covering the leading mRNA and LNP contract manufacturing organizations. Unique pricing comparison for the end-to-end manufacturing process.

LEARN MORE
Optimize your manufacturing process using 50+ established CDMO overviews and a requisite pricing study for small, mid sized and large manufacturers.

Optimize your manufacturing process using 50+ established CDMO overviews and a requisite pricing study for small, mid sized and large manufacturers.

LEARN MORE
Comprehensive analysis of mammalian cell culture CDMOs including price benchmarking, market trends and over 80 company profiles.

Comprehensive analysis of mammalian cell culture CDMOs including price benchmarking, market trends and over 80 company profiles.

LEARN MORE
Over 80 company profiles and analysis of leading microbial fermentation CDMO; exclusive market analysis and price comparison.

Over 80 company profiles and analysis of leading microbial fermentation CDMO; exclusive market analysis and price comparison.

LEARN MORE
Understand the emerging ADC market with profiles on 30 notable CDMOs and an analysis of the value chain of mAbs, linkers and payloads. Benchmark with robust manufacturing pricing.

Understand the emerging ADC market with profiles on 30 notable CDMOs and an analysis of the value chain of mAbs, linkers and payloads. Benchmark with robust manufacturing pricing.

LEARN MORE
Exclusive pricing from 20+ CDMOs and market insight for pDNA as a reagent for advanced therapies and as a primary therapeutic.

Exclusive pricing from 20+ CDMOs and market insight for pDNA as a reagent for advanced therapies and as a primary therapeutic.

LEARN MORE
Robust analysis of gene therapy market, includes 50 company profiles of AAV, Lentiviral and non-viral gene therapy CDMOs.

Robust analysis of gene therapy market, includes 50 company profiles of AAV, Lentiviral and non-viral gene therapy CDMOs.

LEARN MORE
Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

LEARN MORE
Over 80 extensive CDMO profiles for an all-encompassing benchmarking report. Exclusive pricing comparison and updated global GMP regulatory landscape

Over 80 extensive CDMO profiles for an all-encompassing benchmarking report. Exclusive pricing comparison and updated global GMP regulatory landscape

LEARN MORE
Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

LEARN MORE

Subscribe for the Newsletter

Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of topics.

The Road To Series

030db6fe-32bf-4364-88b0-28655c88acf9
ea932e33-29ac-48c3-9e59-fea0994b10cc
cfe49a93-d81b-451e-9e07-8ba4ebfc53b8
8887a25b-41b6-430d-8d52-9722c7334914
2c58207c-1481-4629-bd23-de0d0815f2b1
e6bf6f4c-ce04-4ec3-9aa9-6c34b1c2494f